With a national enterprise technology center and national postdoctoral research workstation, the company is a national high-tech enterprise,a national intellectual property demonstration enterprise, and also a technological innovation demonstration enterprise in Sichuan Province, totally obtaining 9 grants in “National Critical New Medicines Creation Special Projects” in National Science and Technology Major Project, 1 grant in “National Key R&D Program”, 1 grant in “Made in China 2025” Industrial Transformation and Upgrading Projects and 13 grants in provincial and ministerial projects such as provincial major science and technology special projects and science and technology support projects. The Company has been recognized by national, provincial and ministerial government departments and research institutes in technology and R&D capability, which is a member unit of China Pediatric Drugs Development and Industrialization Alliance.

　　The Company had been awarded "Top 20 Best Industrial Enterprises for Pharmaceutical R&D Product Line in China" by China Pharmaceutical Industry Information Center  for eight  consecutive years and "Top 20 Innovative Pharmaceutical Enterprises in China" by China State Institute of Pharmaceutical Industry for eight consecutive years from 2015 to 2022.